Amarin Corp Plc (AMRN)

[ferretmoney]

The intransigence of the FDA with respect to the ITC case; to wit, their failure to enforce the line between dietary supplement and prescription drug, makes me skeptical about the claims some make that the FDA harbors no ill will at this point toward Amarin and that we will receive fair treatment regarding an expanded label. The FTA has to be concerned about the rotting skeleton in their closet, the corruption they engaged in before and during the adcom.